Patients with cancer on the ICU: the times they are changing

A recent paper by Taccone and coworkers showed that 15% of patients from 198 European intensive care units (ICUs) had a malignancy, mostly solid tumors but also hematological malignancies. Over the past years, the prognosis of cancer patients has improved significantly, even when ICU admission is ne...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jonge, Evert, Bos, Monique M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689457/
https://www.ncbi.nlm.nih.gov/pubmed/19291271
http://dx.doi.org/10.1186/cc7721
_version_ 1782167795429015552
author de Jonge, Evert
Bos, Monique M
author_facet de Jonge, Evert
Bos, Monique M
author_sort de Jonge, Evert
collection PubMed
description A recent paper by Taccone and coworkers showed that 15% of patients from 198 European intensive care units (ICUs) had a malignancy, mostly solid tumors but also hematological malignancies. Over the past years, the prognosis of cancer patients has improved significantly, even when ICU admission is necessary. Refusal of ICU admission should not be based on a diagnosis of cancer as the underlying condition. In contrast, these decisions should be based on the availability of treatment options, and on patients' own preferences.
format Text
id pubmed-2689457
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26894572010-03-02 Patients with cancer on the ICU: the times they are changing de Jonge, Evert Bos, Monique M Crit Care Commentary A recent paper by Taccone and coworkers showed that 15% of patients from 198 European intensive care units (ICUs) had a malignancy, mostly solid tumors but also hematological malignancies. Over the past years, the prognosis of cancer patients has improved significantly, even when ICU admission is necessary. Refusal of ICU admission should not be based on a diagnosis of cancer as the underlying condition. In contrast, these decisions should be based on the availability of treatment options, and on patients' own preferences. BioMed Central 2009 2009-03-02 /pmc/articles/PMC2689457/ /pubmed/19291271 http://dx.doi.org/10.1186/cc7721 Text en Copyright © 2009 BioMed Central Ltd
spellingShingle Commentary
de Jonge, Evert
Bos, Monique M
Patients with cancer on the ICU: the times they are changing
title Patients with cancer on the ICU: the times they are changing
title_full Patients with cancer on the ICU: the times they are changing
title_fullStr Patients with cancer on the ICU: the times they are changing
title_full_unstemmed Patients with cancer on the ICU: the times they are changing
title_short Patients with cancer on the ICU: the times they are changing
title_sort patients with cancer on the icu: the times they are changing
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689457/
https://www.ncbi.nlm.nih.gov/pubmed/19291271
http://dx.doi.org/10.1186/cc7721
work_keys_str_mv AT dejongeevert patientswithcancerontheicuthetimestheyarechanging
AT bosmoniquem patientswithcancerontheicuthetimestheyarechanging

Ejemplares similares